HC Wainwright & Co. Reiterates Buy on AC Immune, Maintains $16 Price Target
Portfolio Pulse from richadhand@benzinga.com
HC Wainwright & Co. analyst Andrew Fein has reiterated a 'Buy' rating on AC Immune (NASDAQ:ACIU) and maintained a $16 price target.

June 28, 2023 | 10:16 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
HC Wainwright & Co. has reiterated a 'Buy' rating on AC Immune, maintaining a $16 price target. This could potentially boost investor confidence in the stock.
Analyst ratings and price targets can significantly influence investor sentiment and stock prices. A reiterated 'Buy' rating and maintained price target from a reputable firm like HC Wainwright & Co. could potentially boost investor confidence in AC Immune, leading to a short-term increase in its stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100